// App-Quantinova.ai

PO‐146 : Audit of ‘Door to Needle’ time in administration of prothrombin complex concentrate to patients requiring urgent reversal of anticoagulation

Researchers

Presenter

  • S Elshafie

Principal Investigators

  • S Lee

  • N Smith

Medical Centers

  • Heart of England NHS Foundation Trust, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • Prothrombin

Drug/Treatment

  • Prothrombin complex

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved